F-group (family)
4019.1.1.6 Beta-lactamase2
Ligands and drugs
1,212
Member domains
966
with ligand contacts (≤ 4 Å)
79.7% of members
835
with DrugDomain annotations
68.9% of members
552
with a DrugBank compound
45.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4019.1.1.6 belongs to X-group 4019 alpha-helical domain in beta-lactamase/transpeptidase-like proteins, which binds 8.4 ligand superclasses per 20 proteins, broader than 65% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03834 | TBE | (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine | 17 |
| DB04035 | CB4 | Ceftazidime BATSI | 14 |
| DB08375 | CEF | (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid | 14 |
| DB04133 | CED | Degraded Cephaloridine | 13 |
| DB03530 | CAZ | Acylated ceftazidime | 12 |
| DB09324 | 0RN | Sulbactam | 9 |
| DB12107 | 4D6 | Vaborbactam | 8 |
| DB00766 | J01 | Clavulanic acid | 7 |
| DB00493 | CE3 | Cefotaxime | 6 |
| DB03658 | AXL | (2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 5 |
| DB06889 | 1CE | 3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one | 4 |
| DB00355 | AZR | Aztreonam | 3 |
| DB01053 | PNN | Benzylpenicillin | 3 |
| DB02579 | AKR | Acrylic Acid | 3 |
| DB02841 | NBF | [(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid | 3 |
| DB03709 | BCN | Bicine | 3 |
| DB04360 | BZB | Benzo[B]Thiophene-2-Boronic Acid | 3 |
| DB00319 | WPP | Piperacillin | 2 |
| DB00713 | 105 | Oxacillin | 2 |
| DB02517 | DGL | D-Glutamic Acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NXL | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide | 52 |
| CL | CHLORIDE ION | 47 |
| TSL | TRANS-ENAMINE INTERMEDIATE OF SULBACTAM | 34 |
| 9F2 | Ceftriaxone | 32 |
| NAmetal | SODIUM ION | 28 |
| BO4 | BORATE ION | 20 |
| Kmetal | POTASSIUM ION | 17 |
| TBE | TAZOBACTAM INTERMEDIATE | 17 |
| CB4 | PINACOL[[2-AMINO-ALPHA-(1-CARBOXY-1-METHYLETHOXYIMINO)-4-THIAZOLEACETYL]AMINO]METHANEBORONATE | 14 |
| IM2 | (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 14 |
| CED | 5-METHYL-2-[2-OXO-1-(2-THIOPHEN-2-YL-ACETYLAMINO)-ETHYL]-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | 13 |
| PNM | OPEN FORM - PENICILLIN G | 13 |
| CAZ | ACYLATED CEFTAZIDIME | 12 |
| IOD | IODIDE ION | 12 |
| YCH | [(4~{S})-2-oxidanyl-1,3,2-dioxaborolan-4-yl]methanol | 12 |
| 4D6 | Vaborbactam | 10 |
| CE4 | (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | 10 |
| 0RN | SULBACTAM | 9 |
| FZS | (2R)-2-[(1S)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-hydroxyethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | 9 |
| ZNmetal | ZINC ION | 9 |